Controlled Substances Regulations (SOR/2025-242)

Marginal note:Suspension

• The following provision is not in force.

  219 (1) Subject to subsection (2), the Minister must immediately suspend an export permit if

  • The following provision is not in force.

    (a) the Minister has reasonable grounds to believe that the suspension is necessary to protect public health or safety, including to prevent a controlled substance from being diverted to an illicit market or use; or

  • The following provision is not in force.

    (b) the Minister has reasonable grounds to believe that the exportation would contravene the laws of the country of final destination or any country of transit or transhipment.

• The following provision is not in force.

  Marginal note:Notice

  (2) The suspension takes effect as soon as the Minister provides the government laboratory with a written notice that

  • The following provision is not in force.

    (a) sets out the reasons for the suspension;

  • The following provision is not in force.

    (b) gives the government laboratory an opportunity to be heard; and

  • The following provision is not in force.

    (c) if applicable, specifies the corrective measures that must be carried out and the date by which they must be carried out.

• The following provision is not in force.

  Marginal note:Reinstatement of permit

  (3) The Minister must reinstate the export permit if the Minister has reasonable grounds to believe that the suspension is no longer necessary.

Marginal note:Revocation

• The following provision is not in force.

  220 (1) The Minister must revoke an export permit if

  • The following provision is not in force.

    (a) the government laboratory requests the Minister to do so or informs the Minister of the loss or theft of the permit or the actual or potential unauthorized use of the permit;

  • The following provision is not in force.

    (b) the government laboratory does not carry out the corrective measures specified by the Minister under paragraph 219(2)(c) by the specified date; or

  • The following provision is not in force.

    (c) the Minister has reasonable grounds to believe that the government laboratory submitted misleading information or falsified documents in or in support of the application for the permit.

• The following provision is not in force.

  Marginal note:Prior notice

  (2) Before revoking an export permit, the Minister must

  • The following provision is not in force.

    (a) provide the government laboratory with a prior written notice that sets out the Minister’s reasons and gives the government laboratory an opportunity to be heard; and

  • The following provision is not in force.

    (b) consider the government laboratory’s submissions, if applicable.

Marginal note:Authorization

221 A particular person may sell or provide a controlled substance to a licensed dealer, pharmacist or police force for the purposes of destruction.

Marginal note:Authorization

222 A particular person may deliver, send or transport a controlled substance to a licensed dealer, pharmacist or police force for the purposes of destruction.

Marginal note:Transportation and provision

223 An individual who has obtained, in accordance with the provisions of the Act and its regulations, a controlled substance identified in a prescription for another individual named in that prescription may deliver, transport, sell or provide the substance to that individual.

Marginal note:Return for destruction

224 An individual who has reasonable grounds to believe that a controlled substance in their possession was obtained in accordance with the provisions of the Act and its regulations may, for the purposes of destruction, deliver, transport, sell or provide the substance directly to one of the following persons:

• The following provision is not in force.

  (a) a pharmacist or pharmacy technician, other than one who is practising in a hospital;

• The following provision is not in force.

  (b) a practitioner, other than one who is practising in a hospital;

• The following provision is not in force.

  (c) a hospital; or

• The following provision is not in force.

  (d) a particular person.

Marginal note:Import

225 On entering Canada, an individual may import a substance containing a controlled substance set out in any of Schedules 1 to 3 that is in their actual possession or that forms part of their baggage if

• The following provision is not in force.

  (a) the individual is importing the substance

  • (i) for their own use,

  • (ii) for the use and on the behalf of an accompanying individual, or

  • (iii) for administration to an animal for which the individual is responsible and that is accompanying the individual;

• The following provision is not in force.

  (b) the substance is declared to a customs officer at the port of entry into Canada;

• The following provision is not in force.

  (c) the substance, except a finished product referred to in subsection 98(2) that contains low-dose codeine phosphate, is in a container obtained from a health care provider and that container carries a label on which the following information appears:

  • (i) the name of the individual for whom, or the animal for which, the substance was lawfully obtained,

  • (ii) the name of the health care provider who authorized the substance to be obtained,

  • (iii) with respect to the substance,

    • (A) its name or, if applicable, brand name,

    • (B) its form, strength and quantity, and

    • (C) its drug identification number, if any, and

  • (iv) the daily dose of the substance authorized by the health care provider; and

• The following provision is not in force.

  (d) the imported quantity of the substance does not exceed a 90-day supply required to treat a condition, based on the daily dose shown on the label.

Marginal note:Export

226 On departing Canada, an individual may export a substance containing a controlled substance set out in any of Schedules 1 to 3 that is in their actual possession or that forms part of their baggage if

• The following provision is not in force.

  (a) the individual is exporting the substance

  • (i) for their own use,

  • (ii) for the use and on the behalf of an accompanying individual, or

  • (iii) for administration to an animal for which the individual is responsible and that is accompanying the individual;

• The following provision is not in force.

  (b) the substance, except a finished product referred to in subsection 98(2) that contains low-dose codeine phosphate, is in a container obtained from a health care provider and that container carries a label on which the following information appears:

  • (i) the name of the individual for whom, or the animal for which, the substance was lawfully obtained,

  • (ii) the name of the health care provider who authorized the substance to be obtained,

  • (iii) with respect to the substance,

    • (A) its name or, if applicable, brand name,

    • (B) its form, strength and quantity, and

    • (C) its drug identification number, if any, and

  • (iv) the daily dose of the substance authorized by the health care provider; and

• The following provision is not in force.

  (c) the exported quantity of the substance does not exceed a 90-day supply required to treat a condition, based on the daily dose shown on the label.

Marginal note:Application

227 Only sections 1, 7 to 33 and 228 to 234 apply to a test kit.

Marginal note:Requirement to obtain registration number

228 The following persons are required to obtain a registration number for a test kit:

• The following provision is not in force.

  (a) a person that intends to produce a test kit; and

• The following provision is not in force.

  (b) a person for whom another person, in accordance with a custom order, intends to produce a test kit.

Marginal note:Application for registration number

• The following provision is not in force.

  229 (1) An application to obtain a registration number for a test kit must be submitted to the Minister and contain the following information with respect to the test kit:

  • The following provision is not in force.

    (a) its brand name;

  • The following provision is not in force.

    (b) a detailed description of its design and construction;

  • The following provision is not in force.

    (c) with respect to the controlled substance set out in any of Schedules 1 to 4 and any other substance it contains, their names, forms and quantities;

  • The following provision is not in force.

    (d) a description of its proposed use; and

  • The following provision is not in force.

    (e) its directions for use.

• The following provision is not in force.

  Marginal note:Signature and attestation

  (2) The application must

  • The following provision is not in force.

    (a) be signed and dated by the person authorized by the applicant for that purpose; and

  • The following provision is not in force.

    (b) include an attestation by that person that all of the information submitted in support of the application is correct and complete to the best of their knowledge.

• The following provision is not in force.

  Marginal note:Additional information and documents

  (3) The applicant must, not later than the date specified in the Minister’s written request to that effect, provide the Minister with any information or document that the Minister determines is necessary to complete the review of the application.

Marginal note:Issuance of registration number

• The following provision is not in force.

  230 (1) Subject to section 231, on completion of the review of the application for a registration number, the Minister must issue to the applicant a document that sets out a registration number for the test kit, preceded by the letters “TK”, if the Minister determines that the test kit will only be used for a medical, laboratory, industrial, educational, law administration or enforcement, or research purpose.

• The following provision is not in force.

  Marginal note:Registration number integrity

  (2) A person must not alter or deface in any manner the document that sets out the registration number.

Marginal note:Refusal to issue registration number

• The following provision is not in force.

  231 (1) The Minister must refuse to issue a registration number for a test kit if the Minister has reasonable grounds to believe that

  • The following provision is not in force.

    (a) the test kit poses a risk to public health or safety, including the risk that the controlled substance in the test kit could be diverted to an illicit market or use, because

    • (i) the total amount of the controlled substance is too high, or

    • (ii) the adulterating or denaturing agent in the test kit is not likely to prevent or deter the consumption of the controlled substance in the test kit by an individual or animal or the administration of that substance to an individual or animal; or

  • The following provision is not in force.

    (b) the test kit will be used for a purpose other than one referred to in subsection 230(1).

• The following provision is not in force.

  Marginal note:Prior notice

  (2) Before refusing to issue a registration number, the Minister must

  • The following provision is not in force.

    (a) provide the applicant with a prior written notice that sets out the Minister’s reasons and gives the applicant an opportunity to be heard; and

  • The following provision is not in force.

    (b) consider the applicant’s submissions, if applicable.

Marginal note:Notice to Minister

232 A person must inform the Minister in writing of any of the following facts within 30 days after their occurrence:

• The following provision is not in force.

  (a) the person has ceased to conduct all activities authorized under section 234 with respect to the test kit;

• The following provision is not in force.

  (b) the person has transferred the production of the test kit to another person;

• The following provision is not in force.

  (c) the person has increased the quantity of the controlled substance in the test kit;

• The following provision is not in force.

  (d) the person has changed the brand name of the test kit;

• The following provision is not in force.

  (e) the person has altered in any manner the adulterating or denaturing agent in the test kit or changed the quantity of either agent in it; or

• The following provision is not in force.

  (f) the person has substituted the adulterating or denaturing agent with another one.